Purchases and Sales Made in Q3 2023 in Sab Biotherapeutics, Inc. (SABS)
This table provides information about the institutional ownership of Sab Biotherapeutics, Inc. (SABS) during Q3 2023. The information is specifically focused on institutions that hold shares of SAB Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 08, 2023
Q3 2023
|
Pathstone Family Office, LLC
Englewood, NJ |
BUY
|
- |
507KNew |
$238K - $456K
|
507K
$1.57M
|
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
55.8K+ 18.58% |
$26.2K - $50.3K
|
356K
$1.1M
|
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
27.8K+ 147.0% |
$13.1K - $25K
|
46.7K
$145K
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
14.2K+ 1.47% |
$6.67K - $12.8K
|
977K
$3.03M
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
3.7K+ 6.8% |
$1.74K - $3.33K
|
58.1K
$180K
|
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
395+ 2.72% |
$186 - $356
|
14.9K
$46.3K
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
69New |
$32.4 - $62.1
|
69
$214
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
46+ 5.22% |
$21.6 - $41.4
|
927
$2.87K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
21+ 8.5% |
$9.87 - $18.9
|
268
$831
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-274- 5.1% |
$129 - $247
|
5.09K
$15.8K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.9K- 10.98% |
$893 - $1.71K
|
15.4K
$47.8K
|